주입 펌프 시장 : 유형별, 채널별, 용도별, 최종사용자별 - 세계 예측(-2030년)

Infusion Pumps Market by Type (Volumetric, Syringe, Insulin, Ambulatory Implantable), Channel (Single, Multi) Application (Oncology, Pain, Diabetes, Hematology, Pediatrics) End User (Hospital, Ambulatory Care) - Global Forecast to 2030

US $ 4,175 ￦ 6,215,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회만 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,875 ￦ 8,746,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,875 ￦ 11,724,000

PDF (Global Site License)

PDF 보고서를 동일 기업 및 자회사의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

수액 펌프 시장은 2023-2030년 8.3%의 연평균 복합 성장률(CAGR)로 성장하여 2030년까지 259억 달러에 달할 것으로 예상됩니다.

이 보고서는 광범위한 2차 및 1차 조사, 시장 시나리오에 대한 심층 분석을 통해 주요 산업 촉진요인, 억제요인, 시장 성장 촉진요인 및 과제에 대한 분석을 제공합니다.

외래용 수액 펌프에 대한 수요 증가, 노인 인구의 급증에 따른 만성질환 유병률 증가, 수술 건수 증가, 재택의료에 대한 인식 증가 등이 시장 성장의 원동력이 되고 있습니다. 그러나 수액 펌프의 잦은 제품 리콜, 재생 수액 펌프 및 대여 수액 펌프의 채택 증가, 엄격한 규제 요건 등이 이 시장의 성장을 저해하고 있습니다.

또한, 신흥 시장과 IoT 수액 펌프와 같은 특수 수액 시스템의 채택 확대는 수액 펌프 시장 진출기업들에게 큰 비즈니스 기회를 가져다주고 있습니다. 그러나 투약 오류 증가와 병원 내 무선 연결의 부족은 이 시장의 성장에 영향을 미치는 도전 과제입니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 인사이트

• 개요
• 성장 촉진요인
• 성장 억제요인
• 기회
• 과제
• Porter의 Five Forces 분석
• 규제 분석
• 사례 연구/이용 사례

제5장 주입 펌프 시장 규모·동향 분석 : 제품별

• 개요
• 장비
  • 유형별
    • 용량형 주입 펌프
    • 시린지 주입 펌프
    • 인슐린 주입 펌프
    • 외래용 주입 펌프
      • 일회용 주입 펌프
      • 화학요법용 주입 펌프
    • 경장용 주입 펌프
    • PCA 주입 펌프
    • 이식형 주입 펌프
  • 모드별
    • 수동 주입 펌프
    • 자동 주입 펌프
• 주입 펌프용 부속품/소모품

제6장 주입 펌프 시장 규모·동향 분석 : 채널별

• 개요
• 단일 채널 주입 펌프
• 멀티 채널 주입 펌프

제7장 주입 펌프 시장 규모·동향 분석 : 용도별

• 개요
• 당뇨병 관리
• 종양학
• 통증 관리
• 혈액학
• 신생아과/소아과
• 소화기 내과

제8장 주입 펌프 시장 규모·동향 분석 : 최종사용자별

• 개요
• 병원 및 클리닉
• 재택치료
• 학술기관 및 연구기관
• 외래 의료
• 요양시설

제9장 주입 펌프 시장 규모·동향 분석 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 프랑스
  • 이탈리아
  • 영국
  • 스페인
  • 기타 유럽
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
• 중동 및 아프리카

제10장 경쟁 분석

• 개요
• 주요 성장 전략
• 경쟁 벤치마킹
• 경쟁 대시보드
  • 업계 리더
  • 차별화 요인
  • 지도자
  • 신규 기업
• 시장 점유율 분석/시장 순위(2022년)

제11장 기업 개요(사업 개요, 재무 개요, 제품 포트폴리오, 전략적 전개)

• Becton, Dickinson and Company(BD)(미국)
• B. Braun SE(독일)
• Fresenius SE&Co. KGaA.(독일)
• ICU Medical, Inc.(미국)
• Medtronic plc(아일랜드)
• MOOG Inc.(미국)
• Terumo Corporation(일본)
• F. Hoffmann-LA Roche Ltd(스위스)
• Insulet Corporation(미국)
• Baxter International Inc.(미국)

(주 : SWOT 분석은 주요 5개사에 대해 기재)

제12장 부록

LSH

영문 목차

영문목차

Infusion Pumps Market Size, Share, Forecast, & Trends Analysis by Type (Volumetric, Syringe, Insulin, Ambulatory [Disposable, Chemo], Implantable), Channel (Single, Multi), Application (Oncology, Pain, Diabetes, Pediatrics), End User-Global Forecast to 2030

The infusion pumps market is projected to reach $25.9 billion by 2030 at a CAGR of 8.3% from 2023 to 2030.

Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.

The growth of this market is driven by rising demand for ambulatory infusion pumps, the increasing incidence of chronic diseases along with rapid growth in the geriatric population, the growing number of surgical procedures performed, and increased awareness regarding home healthcare. However, frequent product recalls of infusion pumps, the increasing adoption of refurbished and rental infusion pumps, and stringent regulatory requirements restrain the growth of this market.

Furthermore, emerging markets and the growing adoption of specialty infusion systems, such as IoT infusion pumps, are generating significant opportunities for players in the infusion pumps market. However, the increasing incidence of medication errors and lack of wireless connectivity in hospitals are challenges impacting the growth of this market.

The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the infusion pumps market are Becton, Dickinson and Company (BD), B. Braun SE (Germany), Baxter International Inc. (U.S.), Fresenius SE&Co. KGaA. (Germany), ICU Medical, Inc. (U.S.), Medtronic plc (Ireland), MOOG Inc. (U.S.), Terumo Corporation (Japan), F. Hoffmann-LA Roche Ltd (Switzerland), and Insulet Corporation (U.S.).

Based on type, in 2023, the infusion pump accessories/consumables segment is expected to account for the largest share of the infusion pumps market. The recurrent use and repeat purchases of accessories/consumables for infusion therapy support the segment's large share.

Based on channel, in 2023, the multi-channel infusion pumps segment is expected to account for the larger share of the infusion pumps market owing to factors such as the rising demand for technologically advanced infusion pumps, the need for precise delivery of multiple drugs in cases of chronic diseases, rising awareness regarding infusion pumps, and the growing demand for advanced infusion pumps in home healthcare.

Based on application, in 2023, the oncology segment is expected to account for the largest share of the infusion pumps market due to the increasing prevalence of cancer and rising demand for the controlled dispensing of drugs in the body for chemotherapy. Additionally, portable infusion pumps allow patients to receive chemotherapy in their homes, supporting the segment's growth.

Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of the infusion pumps market. Factors such as the large volume of patients served by hospitals, the top line serving a large volume of patients, and the increasing patient pool contribute to the segment's large market share.

An in-depth analysis of the geographical scenario in the infusion pumps market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the infusion pumps market. Further, in 2023, the U.S. is expected to account for the major share of the infusion pumps market in North America. However, Asia-Pacific is projected to witness the fastest growth during the forecast period due to increased government support for technology adoption in the healthcare sector, rising investments in improving healthcare infrastructure, and increasing awareness and literacy among the population. Furthermore, the growing presence of key companies is also boosting market growth in the region.

Scope of the Report:

Infusion Pumps Market Assessment-by Type

• Devices
  • By Type
• Volumetric Infusion Pumps
• Syringe Infusion Pumps
• Insulin Infusion Pumps
• Ambulatory Infusion Pumps
• Disposable Infusion Pumps
• Chemotherapy Infusion Pumps
• Enteral Infusion Pumps
• PCA Infusion Pumps
• Implantable Infusion Pumps
  • By Mode
• Manual Infusion Pumps
• Automatic Infusion Pumps
• Infusion Pump Accessories/Consumables

Infusion Pumps Market Assessment-by Channel

• Single-channel Infusion Pumps
• Multi-channel Infusion Pumps

Infusion Pumps Market Assessment-by Application

• Diabetes Management
• Oncology
• Pain Management
• Hematology
• Neonatology/Pediatrics
• Gastroenterology

Infusion Pumps Market Assessment-by End User

• Hospitals & Clinics
• Home Health Care
• Academic & Research Institutes
• Ambulatory Care Settings
• Nursing Homes

Infusion Pumps Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLATAM)
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition and Scope
• 1.2. Market Ecosystem
• 1.3. Currency and Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection and Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
• 2.3. Market Sizing and Forecast
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3 Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Rising Demand for Ambulatory Infusion Pumps
  • 4.2.2. Increasing Incidence of Chronic Diseases along with the Rapid Growth in the Geriatric Population
  • 4.2.3. Growing Number of Surgical Procedures Performed
  • 4.2.4. Increase in Awareness Towards Home Healthcare
• 4.3. Restraints
  • 4.3.1. Frequent Product Recalls of Infusion Pumps
  • 4.3.2. Increasing Adoption of Refurbished and Rental Infusion Pumps
  • 4.3.3. Stringent Regulatory Requirements for New Products
• 4.4. Opportunities
  • 4.4.1. Emerging Markets
  • 4.4.2. Growing Adoption of Specialty Infusion Systems such as IOT Infusion Pumps
• 4.5. Challenges
  • 4.5.1. Increasing Incidence of Medication Errors and Lack of Wireless Connectivity in Hospitals
• 4.6. Porter's Five Forces Analysis
• 4.7. Regulatory Analysis
• 4.8. Case Studies/Use Cases

5. Infusion Pumps Market Size & Trend Analysis-by Product

• 5.1. Overview
• 5.2. Devices
  • 5.2.1. By Type
    • 5.2.1.1. Volumetric Infusion Pumps
    • 5.2.1.2. Syringe Infusion Pumps
    • 5.2.1.3. Insulin Infusion Pumps
    • 5.2.1.4. Ambulatory Infusion Pumps
      • 5.2.1.4.1. Disposable Infusion Pumps
      • 5.2.1.4.2. Chemotherapy Infusion Pumps
    • 5.2.1.5. Enteral Infusion Pumps
    • 5.2.1.6. PCA Infusion Pumps
    • 5.2.1.7. Implantable Infusion Pumps
  • 5.2.2. By Mode
    • 5.2.2.1. Manual Infusion Pumps
    • 5.2.2.2. Automatic Infusion Pumps
• 5.3. Infusion Pump Accessories/Consumables

6. Infusion Pumps Market Size & Trend Analysis-by Channel

• 6.1. Overview
• 6.2. Single Channel Infusion Pumps
• 6.3. Multi-channel Infusion Pumps

7, Infusion Pumps Market Size & Trend Analysis-by Application

• 7.1. Overview
• 7.2. Diabetes Management
• 7.3. Oncology
• 7.4. Pain Management
• 7.5. Hematology
• 7.6. Neonatology/Pediatrics
• 7.7. Gastroenterology

8. Infusion Pumps Market Size & Trend Analysis-by End User

• 8.1. Overview
• 8.2. Hospitals & Clinics
• 8.3. Home Health Care
• 8.4. Academic & Research Institutes
• 8.5. Ambulatory Care Settings
• 8.6. Nursing Homes

9. Infusion Pumps Market Size & Trend Analysis-by Geography

• 9.1. Overview
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. Italy
  • 9.3.4. U.K.
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe
• 9.4. Asia-Pacific
  • 9.4.1. China
  • 9.4.2. Japan
  • 9.4.3. India
  • 9.4.4. Rest of Asia-Pacific
• 9.5. Latin America
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America
• 9.6. Middle East & Africa

10. Competition Analysis

• 10.1. Overview
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Competitive Dashboard
  • 10.4.1. Industry Leaders
  • 10.4.2. Differentiators
  • 10.4.3. Vanguards
  • 10.4.4. Emerging Companies
• 10.5. Market Share Analysis/Market Ranking (2022)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

• 11.1. Becton, Dickinson and Company (BD) (U.S.)
• 11.2. B. Braun SE (Germany)
• 11.3. Fresenius SE&Co. KGaA. (Germany)
• 11.4. ICU Medical, Inc. (U.S.)
• 11.5. Medtronic plc (Ireland)
• 11.6. MOOG Inc. (U.S.)
• 11.7. Terumo Corporation (Japan)
• 11.8. F. Hoffmann-LA Roche Ltd (Switzerland)
• 11.9. Insulet Corporation (U.S.)
• 11.10. Baxter International Inc. (U.S.)

(Note: SWOT analysis is provided for the top 5 companies.)

12. Appendix

• 12.1. Available Customization
• 12.2. Related Reports

관련자료